IM Cannabis Corp. (NASDAQ: IMCC) (CSE:IMCC) released financial results for its second quarter ended June 30, 2022, revealing revenues increased 114% year-over-year to CA$23.8 million ($18.43 million). Q2 2022 Financial Results
July 13, 2:45 PM
By Oren Shuster The project, known as “Pain Initiative Cannabinoids 2021”, is a crucial development in advancing the German cannabis industry
July 1, 4:58 PM
Canada is celebrating its national day on Friday, in honor of Confederation, which took place on July 1, 1867. The day is a statutory holiday and the Canadian stock market is closed, making it a good time to check in on the five biggest gainers and losers so far this year.
IM Cannabis Reports Record First Quarter 2022 Financial Results, Revenues Increase 169% YoY To $23.6M
May 12, 10:14 PM
IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC), a medical and adult-use cannabis company with operations in Israel, Canada, and Germany, announced its financial results on Thursday for the three months ended March 31, 2022 (Q1).
February 28, 8:50 PM
The Global Cannabis Stock Index fell for the 12th consecutive month, declining 1.1% to 28.31, reported Alan Brochstein, founder of New Cannabis Ventures and 420 Investor.
December 1, 1:07 PM
IM Cannabis Corp. (CSE: IMCC), (NASDAQ: IMCC) will acquire the majority of Jerusalem’s leading medical cannabis pharmacy, Oranim. The cannabis company confirmed Wednesday that its Israeli subsidiary IMC Holdings Ltd.